Chest Medicine
Retrospective cohort study | Symptoms and risk factors for long COVID in non-hospitalized adults.
19 Aug, 2022 | 16:17h | UTCSymptoms and risk factors for long COVID in non-hospitalized adults – Nature Medicine
Commentary: UK study finds over 100 symptoms of long COVID in non-hospitalized adults – News Medical
M-A | The accuracy of pulse oximetry in measuring oxygen saturation by levels of skin pigmentation.
19 Aug, 2022 | 16:15h | UTCRelated:
Racial Bias in Pulse Oximetry Measurement – New England Journal of Medicine
FDA issues alert on ‘limitations’ of pulse oximeters, without explicit mention of racial bias – STAT
Pulse Oximeter Accuracy and Limitations: FDA Safety Communication – U.S. Food & Drug Administration
RCT | Metformin, Ivermectin, and Fluvoxamine are not beneficial for obese outpatients with Covid-19.
18 Aug, 2022 | 13:00h | UTCEditorial: Time to Stop Using Ineffective Covid-19 Drugs – New England Journal of Medicine
Commentary on Twitter
In this trial involving overweight or obese outpatients with Covid-19, investigators found that none of three repurposed drugs (metformin, ivermectin, and fluvoxamine) reduced the risk of serious disease. https://t.co/8sd6R7CDK6 pic.twitter.com/bPZ6zeuZSA
— NEJM (@NEJM) August 17, 2022
Pooled analysis of drug-related interstitial lung disease and/or pneumonitis in nine trastuzumab deruxtecan monotherapy studies.
18 Aug, 2022 | 12:47h | UTCCommentaries:
Trastuzumab deruxtecan-related ILD/pneumonitis characterized – medwire News
RCT | Effectiveness of a long-term home-based exercise training program in patients with COPD following pulmonary rehabilitation.
18 Aug, 2022 | 12:43h | UTC
Commentary on Twitter
Effectiveness of a long-term home-based exercise training program in patients with COPD following pulmonary rehabilitation: A multi-center randomized controlled trialhttps://t.co/8u1nizaDNq pic.twitter.com/QwqzN1dDHK
— Physio Meets Science (@PhysioMeScience) August 17, 2022
Under a Creative Commons license
Review | Acute respiratory distress syndrome.
17 Aug, 2022 | 14:30h | UTCAcute Respiratory Distress Syndrome – Emergency Medicine Clinics of North America
Guideline | Use of COVID-19 convalescent plasma.
17 Aug, 2022 | 14:28h | UTC
Risk stratification in patients with acute pulmonary embolism: current evidence and perspectives.
17 Aug, 2022 | 13:55h | UTC
Prolonged mechanical ventilation: outcomes and management.
17 Aug, 2022 | 13:53h | UTCProlonged Mechanical Ventilation: Outcomes and Management – Journal of Clinical Medicine
International clinical practice guidelines for pediatric ventilator liberation.
16 Aug, 2022 | 13:56h | UTC
Study suggests long covid symptoms affect 1 in 8 patients.
16 Aug, 2022 | 13:52h | UTCNews Release: Most reliable estimates to date suggest one in eight COVID-19 patients develop long COVID symptoms – Lancet
Commentaries:
Long COVID symptoms affect 1 in 8 adults, some for 2 years – CIDRAP
Covid-19: One in eight adults develops long covid symptoms, study suggests – The BMJ
UK approves updated Moderna vaccine targeting Omicron variant.
16 Aug, 2022 | 13:49h | UTCUK approves updated Moderna vaccine targeting Omicron variant – Associated Press/MedicalXpress
See also: Covid: UK first country to approve dual-strain vaccine – BBC
Review | Chronic hypercapnic respiratory failure and non-invasive ventilation in people with chronic obstructive pulmonary disease.
16 Aug, 2022 | 13:37h | UTC
Commentary on Twitter
🆕 The latest review on non-invasive ventilation aims to provide background for internists to consider this therapeutic option for their #COPD patients. Read it now ▶️ https://t.co/7mnYMPHKEp#MedTwitter #BMJMedicine #CCFCOPD @CCF_PCCM pic.twitter.com/DfmOZxAIjG
— BMJMedicine (@BMJMedicine) August 5, 2022
M-A | Efficacy and safety of heparin full-dose anticoagulation in hospitalized non-critically ill COVID-19 patients.
15 Aug, 2022 | 12:27h | UTCRelated:
Anticoagulants for people hospitalised with COVID‐19 – Cochrane Library
Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019.
12 Aug, 2022 | 14:58h | UTCInvited Commentary: Trends in the global burden of lower respiratory infections: the knowns and the unknowns – The Lancet Infectious Diseases
Commentary on Twitter (thread – click for more)
New Research: Age–sex differences in the global burden of lower respiratory infections and risk factors, 1990–2019: results from the Global Burden of Disease Study 2019 https://t.co/rhV7lRaZvc (1/2) pic.twitter.com/I0INjaMh4I
— The Lancet Infectious Diseases (@TheLancetInfDis) August 12, 2022
M-A | Diagnostic accuracy of urinary antigen tests for pneumococcal pneumonia among patients with acute respiratory failure suspected pneumonia.
12 Aug, 2022 | 14:28h | UTC
M-A | Medications for the treatment of pulmonary arterial hypertension.
12 Aug, 2022 | 14:32h | UTC
RCT | Tobramycin inhalation solution is effective in adults with bronchiectasis with pseudomonas aeruginosa infection.
11 Aug, 2022 | 12:15h | UTCCommentary: Tobramycin Tames Infection in Bronchiectasis – Medscape (free registration required)
Extracorporeal carbon dioxide removal for acute respiratory failure: a review of potential indications, clinical practice and open research questions.
11 Aug, 2022 | 12:02h | UTC
Commentary on Twitter
Extracorporeal carbon dioxide removal #ECCO2r: to date indications & risk-to-beneft ratio of this technique should now be carefully evaluated using structured national or international registries and large randomized trials. Here #FOAMcc narrative review
🖇️https://t.co/CN8OSha8uY https://t.co/zEFBMAF9dW pic.twitter.com/QqPG00QKPU— Intensive Care Medicine (@yourICM) August 10, 2022
Systematic Review | Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
11 Aug, 2022 | 11:59h | UTCInhaled antibiotics for pulmonary exacerbations in cystic fibrosis – Cochrane Library
Systematic Review | Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism.
10 Aug, 2022 | 12:32h | UTC
Systematic Review | Smoking cessation for secondary prevention of cardiovascular disease.
9 Aug, 2022 | 12:42h | UTCSmoking cessation for secondary prevention of cardiovascular disease – Cochrane Library
RCT | Effectiveness of Varenicline and Cytisine for alcohol use reduction among people with HIV and substance use.
9 Aug, 2022 | 12:35h | UTC
Commentary on Twitter
In this RCT, varenicline and cytisine were not more efficacious than nicotine to treat risky drinking and smoking among individuals with HIV; rates of behavior change for alcohol consumption and smoking were high in all treatment groups. #OrigInvestigation https://t.co/h8M6e5nOkf
— JAMA Network Open (@JAMANetworkOpen) August 5, 2022
Systematic Review | Impact of low‐dose computed tomography screening on lung cancer‐related mortality.
8 Aug, 2022 | 11:52h | UTCSummary: Impact of computed tomography (CT) on lung cancer screening – Cochrane Library
Related:
Screening for Lung Cancer: CHEST Guideline and Expert Panel Report.
RCT | Temporary transvenous phrenic nerve stimulation does not benefit difficult-to-wean patients in the ICU.
8 Aug, 2022 | 11:41h | UTC